nul
Announcement of regulated information - transactions notification
Earlier from Lavipharm
- Financial results press release first half 2025
- Announcement of New Head of Corporate Announcements
- A New Strategic Agreement for Further Expansion in International Markets
- 9-month 2024 Key Financial Figures
- Financial results first half of 2024
Later from Lavipharm
- Announcement Appointment of Chief Quality Officer
- Announcement Appointment of Chief Manufacturing & Operations Officer
Follow Lavipharm into a list and get an email when it puts out news.
Follow Lavipharm